Lucid Diagnostics (LUCD) EBT Growth (1y) (2021 - 2026)
Lucid Diagnostics (LUCD) EBT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | -29.12% |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 53.94% |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 12.65% |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 29.89% |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 31.69% |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 13.05% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 71.38% |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 17.94% |
| 10 | Lucid Diagnostics | 176.20 Mn | 142.80 Mn | 55,000.00 | -163.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -163.28% |
| Mar 31, 2026 | 48.31% |
| Dec 31, 2025 | -40.94% |
| Sep 30, 2025 | 15.96% |
| Jun 30, 2025 | 59.66% |
| Mar 31, 2025 | -153.56% |
| Dec 31, 2024 | -6.57% |
| Sep 30, 2024 | 12.93% |
| Jun 30, 2024 | 3.30% |
| Mar 31, 2024 | 34.68% |
| Dec 31, 2023 | 27.45% |
| Sep 30, 2023 | 0.98% |
| Jun 30, 2023 | 22.18% |
| Mar 31, 2023 | -32.41% |
| Dec 31, 2022 | -32.04% |
| Sep 30, 2022 | -106.25% |
| Jun 30, 2022 | -137.29% |
| Mar 31, 2022 | -235.89% |
| Dec 31, 2021 | -313.97% |
| Sep 30, 2021 | -244.12% |